| Dr Mark Russell Witcher, MD | |
|
Dept. Of Neurosurgery, Wake Forest University, Baptist Medical Center, Medical Center Blvd., Winston Salem, NC 27127-7580 | |
| (336) 341-3037 | |
| Not Available |
| Full Name | Dr Mark Russell Witcher |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | Dept. Of Neurosurgery, Wake Forest University, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568606747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 073884 (Georgia) | Secondary |
| 207T00000X | Neurological Surgery | 0101260948 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carilion Medical Center | Roanoke, VA | Hospital |
| Carilion New River Valley Medical Center | Christiansburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carilion Medical Center | 9830096585 | 758 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.
The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.
Since its establishment in 2012 by the OIE, the rabies Vaccine Bank has contributed to the elimination of rabies in OIE Member Countries by providing high-quality rabies vaccines at an affordable price and in a timely manner. These vaccines act as triggers for the implementation of mass vaccination campaigns, essential to any effective national rabies elimination strategy.
› Verified 9 days ago
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730123472 PECOS PAC ID: 9830096585 Enrollment ID: O20040107000472 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.
The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.
Since its establishment in 2012 by the OIE, the rabies Vaccine Bank has contributed to the elimination of rabies in OIE Member Countries by providing high-quality rabies vaccines at an affordable price and in a timely manner. These vaccines act as triggers for the implementation of mass vaccination campaigns, essential to any effective national rabies elimination strategy.
› Verified 9 days ago
| Entity Name | Carilion Rockbridge Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174636021 PECOS PAC ID: 4789658261 Enrollment ID: O20040820000838 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.
The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.
Since its establishment in 2012 by the OIE, the rabies Vaccine Bank has contributed to the elimination of rabies in OIE Member Countries by providing high-quality rabies vaccines at an affordable price and in a timely manner. These vaccines act as triggers for the implementation of mass vaccination campaigns, essential to any effective national rabies elimination strategy.
› Verified 9 days ago
| Entity Name | Carilion Giles Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194718304 PECOS PAC ID: 3678670221 Enrollment ID: O20070516000487 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.
The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.
Since its establishment in 2012 by the OIE, the rabies Vaccine Bank has contributed to the elimination of rabies in OIE Member Countries by providing high-quality rabies vaccines at an affordable price and in a timely manner. These vaccines act as triggers for the implementation of mass vaccination campaigns, essential to any effective national rabies elimination strategy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Russell Witcher, MD 213 S Jefferson St Ste 1006, Roanoke, VA 24011-1713 Ph: () - | Dr Mark Russell Witcher, MD Dept. Of Neurosurgery, Wake Forest University, Baptist Medical Center, Medical Center Blvd., Winston Salem, NC 27127-7580 Ph: (336) 341-3037 |
News Archive
Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care settings.
A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuron suggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer's disease.
The Medical Research Council (MRC) and the National Institute for Health Research (NIHR) have announced a new joint arrangement for clinical trials. The initiative forms a key part of the developing MRC- NIHR joint strategy for translational research.
Since its establishment in 2012 by the OIE, the rabies Vaccine Bank has contributed to the elimination of rabies in OIE Member Countries by providing high-quality rabies vaccines at an affordable price and in a timely manner. These vaccines act as triggers for the implementation of mass vaccination campaigns, essential to any effective national rabies elimination strategy.
› Verified 9 days ago
Dennis Michael Campbell, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Kimel Park Dr Ste 100, Winston Salem, NC 27103 Phone: 336-765-6637 | |
Dr. Otis Delano Curling Jr., MD, MBA Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 730 Highland Oaks Dr, Suite 105, Winston Salem, NC 27103 Phone: 336-409-4847 Fax: 336-450-1001 | |
Adrian Walter Laxton, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-4081 Fax: 336-716-3065 | |
Daniel Edward Couture, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-4081 Fax: 336-716-3065 | |
Dr. Rashid Mazhar Janjua, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Kimel Park Dr, Ste 201, Winston Salem, NC 27103 Phone: 336-765-6637 Fax: 336-765-6964 | |
Dr. Phillip Robert Dagostino, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 617-851-5987 | |
David J Hart, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 185 Kimel Park Dr Ste 201, Winston Salem, NC 27103 Phone: 336-765-6637 Fax: 336-765-6964 |